Application Deadline: 29 January 2024.
LOCATION: United Kingdom.
GSK having previously funded 20 projects through the Africa NCD Open Lab until the last call for proposals in 2022, are now calling for research proposals focussed on funding high-quality infectious disease research that has the potential to deliver significant health impact and develop future research leaders, with up to £100,000 available per award. Along with the award they offer mentoring, scientific and technical support while you conduct your innovative research project.
ELIGIBILITY:
The principal investigator must be an African scientist in the early stages of their research and academic career, defined as: a basic biomedical scientist, clinically qualified investigator, or public health researcher, who has not previously competed successfully as principal investigator for a major research grant (>£100,000), and who is no more than five years from their highest postgraduate qualification (career breaks and time out of academic research will be taken into consideration).
The minimum formal qualification required is a graduate degree. Most applicants will be expected to have a MSc, PhD or an MD. Applicants can hold a lecturer appointment, a junior fellowship, or be in another research staff position.
Must demonstrate a track record and ongoing commitment to health-related research and the skills and experience required to carry out the proposed work. Evidence of research output, including publications in peer reviewed journals, conference publications, presentations at scientific conferences, input into clinical guidelines or policy documents is required.
Employed by a research or academic institution in SSA. Additionally, applications are strongly encouraged from historically underrepresented population groups and institutions.
A national of a sub-Saharan African country and based in an institution in SSA.
The research project – your project must meet the following criteria
Research proposal of relevance to disease understanding in the following disease areas:
Malaria
Tuberculosis
Antimicrobial resistance (AMR) linked to these infectious diseases
Enteric infections
Other (Neglected Tropical Disease and emerging infectious diseases of particular relevance for Africa)
BENEFIT:
Up to £100,000 available per award to cover a project for up to 36 months.
The award will offer funding to cover the costs of an appropriate research project including costs for equipment, field work and data collection, consumables, and research assistance.
There will be opportunities to undertake training activities relevant to achieving the aims of the project or research career development, including short courses and training visits to relevant research institutions, to be agreed in consultation with GSK.
In addition to financial support, GSK will provide scientific support throughout the duration of the award term. The level of interaction will be determined through the application process and will be tailored to the individual needs of the project. GSK will explore links with scientists from academic and research groups in Africa and globally to provide mentorship to successful applicants.
Funding is not provided for degree/fellowship tuition fees.